Novel phosphorus-containing 17β-side chain mifepristone analogues as progesterone receptor antagonists

被引:24
作者
Jiang, Weiqin [1 ]
Allan, George [1 ]
Chen, Xin [1 ]
Fiordeliso, James J. [1 ]
Linton, Olivia [1 ]
Tannenbaum, Pamela [1 ]
Xu, Jun [1 ]
Zhu, Peifang [1 ]
Gunnet, Joseph [1 ]
Demarest, Keith [1 ]
Lundeen, Scott [1 ]
Sui, Zhihua [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Drug Discovery, Raritan, NJ 08869 USA
关键词
C-17 phosphorus-containing steroids; selective progesterone receptor antagonist;
D O I
10.1016/j.steroids.2006.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel series of steroidal compounds were designed and synthesized with various phosphorus-containing groups on the 17 beta-side chain as progesterone receptor antagonists. The structure -activity relationships of these compounds are discussed. Selected compounds were tested in an rat progesterone-sensitive assay. Some of these compounds are more potent than mifepristone, with a better selectivity profile in differentiating progesterone receptor from glucocorticoid receptor. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:949 / 954
页数:6
相关论文
共 19 条
[1]   Lithium bis-(diisopropylamino)boracetylide [LiC=C-B(Ni-Pr-2)(2)]. A new reagent for the preparation of terminal alkynes [J].
Blanchard, C ;
Vaultier, M ;
Mortier, J .
TETRAHEDRON LETTERS, 1997, 38 (51) :8863-8866
[2]   Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy [J].
DeManno, D ;
Elger, W ;
Garg, R ;
Lee, R ;
Schneider, B ;
Hess-Stumpp, H ;
Schubert, G ;
Chwalisz, K .
STEROIDS, 2003, 68 (10-13) :1019-1032
[3]   Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget [J].
Fensome, A ;
Bender, R ;
Chopra, A ;
Cohen, J ;
Collins, MA ;
Hudak, V ;
Malakian, K ;
Lockhead, S ;
Olland, A ;
Svenson, K ;
Terefenko, EA ;
Unwalla, RJ ;
Wilhelm, JM ;
Wolfrom, S ;
Zhu, Y ;
Zhang, ZM ;
Zhang, PW ;
Winneker, RC ;
Wrobel, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) :5092-5095
[4]   Novel 5-aryl-1,3-dihydro-indole-2-thiones: Potent, orally active progesterone receptor agonists [J].
Fensome, A ;
Koko, M ;
Wrobel, J ;
Zhang, PW ;
Zhang, ZM ;
Cohen, J ;
Lundeen, S ;
Rudnick, K ;
Zhu, YA ;
Winneker, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (07) :1317-1320
[5]   New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles [J].
Fensome, A ;
Bender, R ;
Cohen, J ;
Collins, MA ;
Mackner, VA ;
Miller, LL ;
Ullrich, JW ;
Winneker, R ;
Wrobel, J ;
Zhang, PW ;
Zhang, ZM ;
Zhu, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) :3487-3490
[6]   Progesterone receptor antagonists (antiprogestins) [J].
Hess-Stumpp, H ;
Hoffmann, J ;
Fuhrmann, U .
DRUGS OF THE FUTURE, 2002, 27 (11) :1113-1123
[7]   The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain -: RU-486 induces a transconformation that leads to active antagonism [J].
Kauppi, B ;
Jakob, C ;
Färnegårdh, M ;
Yang, J ;
Ahola, H ;
Alarcon, M ;
Calles, K ;
Engström, O ;
Harlan, J ;
Muchmore, S ;
Ramqvist, AK ;
Thorell, S ;
Öhman, L ;
Greer, J ;
Gustafsson, JÅ ;
Carlstedt-Duke, J ;
Carlquist, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) :22748-22754
[8]   Syntheses and GABA receptor binding properties of 4-amino-1-, 2-, and 3-hydroxybutylphosphinic acids [J].
Kehler, J ;
Ebert, B ;
Dahl, O ;
Krogsgaard-Larsen, P .
TETRAHEDRON, 1999, 55 (03) :771-780
[9]  
KETTEL LM, 1991, FERTIL STERIL, V56, P402
[10]   Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone [J].
Lundeen, SG ;
Zhang, ZM ;
Zhu, Y ;
Carver, JM ;
Winneker, RC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 78 (02) :137-143